It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance.
I have posted the link to this Webcast under Newswire. It is very good and includes interviews with some of the most respected names in the world of CML. take a look at it, especially those who are newly diagnosed or those who have questions about monitoring and/or the importance of adherance to therapy.
It was nice for me to see and hear Carolyn Blasdel who, as Dr. Druker's clinical research nurse, monitored my response and treatment at OHSU when I took part in the phase ll trial there during in August, September and October '99.
I am sure this webcast will be of interest to many of you.
Sandy